Menu
Search
|

Menu

Close
X

NanoString Technologies Inc NSTG.OQ (NASDAQ Stock Exchange Global Market)

15.16 USD
-0.43 (-2.76%)
As of Oct 19
chart
Previous Close 15.59
Open 15.57
Volume 40,804
3m Avg Volume 80,817
Today’s High 15.89
Today’s Low 15.04
52 Week High 18.86
52 Week Low 5.87
Shares Outstanding (mil) 29.79
Market Capitalization (mil) 464.99
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.40 Mean rating from 5 analysts

KEY STATS

Revenue (mm, USD)
FY18
48
FY17
115
FY16
86
FY15
63
EPS (USD)
FY18
-1.553
FY17
-0.387
FY16
-2.345
FY15
-2.411
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.14
Price to Sales (TTM)
vs sector
4.21
6.55
Price to Book (MRQ)
vs sector
46.71
4.00
Price to Cash Flow (TTM)
vs sector
--
21.51
Total Debt to Equity (MRQ)
vs sector
576.99
14.15
LT Debt to Equity (MRQ)
vs sector
576.99
11.31
Return on Investment (TTM)
vs sector
-23.44
12.83
Return on Equity (TTM)
vs sector
-73.44
14.95

EXECUTIVE LEADERSHIP

William Young
Independent Chairman of the Board, Since 2010
Salary: --
Bonus: --
R. Bradley Gray
President, Chief Executive Officer, Director, Since 2010
Salary: $561,667.00
Bonus: --
K. Thomas Bailey
Chief Financial Officer, Treasurer, Since 2018
Salary: --
Bonus: --
J. Chad Brown
Senior Vice President - Sales and Marketing, Since 2017
Salary: $178,522.00
Bonus: --
Mary Allen
Senior Vice President - Operations, Since 2017
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Medical Equipment, Supplies & Distribution
Address:

530 Fairview Ave N
SEATTLE   WA   98109-5553

Phone: +1206.3786266

NanoString Technologies, Inc. develops, manufactures and sells intuitive products that unlock scientifically valuable and clinically actionable biologic information from minute amounts of tissue. The Company is engaged in the development, manufacture and commercialization of instruments, consumables and services for profiling the activity of hundreds of genes and proteins simultaneously from a single tissue sample. The Company's nCounter Analysis System is an automated, multi-application, digital detection and counting system, which directly profiles hundreds of molecules simultaneously using a barcoding technology. The Company markets systems and related consumables to researchers in academic, government and biopharmaceutical laboratories for use in understanding fundamental biology and the molecular basis of diseases, such as cancer, and to clinical laboratories and medical centers for diagnostic use.

SPONSORED STORIES